MillionMilesAway
Well-Known Member
Oxford trial leader on BBC now.
Didn't add much other than to confirm that the 62% is two full doses, and that they are still looking at the data to understand the 90% result.
Apparently this one is not-for-profit.
Didn't add much other than to confirm that the 62% is two full doses, and that they are still looking at the data to understand the 90% result.
Apparently this one is not-for-profit.
Last edited: